Is it known whether deucravacitinib passes into human breast milk?

It is unknown whether deucravacitinib or its metabolites pass into human milk; animal data show milk excretion, infant risk cannot be excluded, and a decision between stopping breastfeeding or stopping/avoiding treatment must consider the benefits of breastfeeding for the child and treatment for the woman.